All In Biotech

Drug Trial Radar · NCT00270257

Drug Treatment Combined With Drug and Risk Reduction Counseling to Prevent of HIV Infection and Death Among Injection Drug Users

A Phase III Randomized Controlled Trial to Evaluate the Efficacy of Drug Treatment in Prevention of HIV Infection and Death Among Opiate Dependent Injectors

Last checked: Nov 19, 2026Latest source record: Nov 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingPhase 3. Randomized with 1,251 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

1,251

Actual

Start

May 2008

Primary completion

Jul 2012

Study completion Jul 2012

Sponsor

Sponsor type
NIH
Collaborators
National Institute on Drug Abuse (NIDA)
First posted
Dec 26, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Drug abuse and HIV/AIDS are serious global health problems. Injection drug use is currently the major mode of transmission of HIV in many countries. The purpose of this study is to determine the effectiveness of drug and risk reduction counseling combined with either substitution drug treatment with buprenorphine/naloxone (BUP/NX) or short-term detoxification with BUP/NX in preventing HIV transmission among injection drug users. Participants will be recruited for this study in China and Thailand.

Conditions

  • HIV Infections
  • Opioid-Related Disorders

Interventions

  • Buprenorphine/NaloxoneDrug

    Oral tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evidence of HIV-1 Infection or Death for Visits up to 104 WeeksTime frame: For visits up to week 104

Locations

4 sites in 2 countries. Site status is shown where the registry gives one.

  • Heng County Ctr. for Disease Control & Prevention CRS

    Hengzhou Town, Guangxi, China

  • Guangxi Ctrs. for Disease Control & Prevention and for HIV/AIDS Prevention & Control CRS

    Nanning, Guangxi, China

  • Xinjiang CRS

    Ürümqi, Xinjiang, China

  • CMU HIV Prevention CRS

    Chiang Mai, Thailand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.